4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-031038
Chief Legal Officer sold 20,416 shares at an average $23.45 ($478,845)
- Chief Legal Officer acquired 20,416 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ali-Jackson Kamil · Chief Legal Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-06 | Exercise or conversion : show line 1 in the form | +15,000 | $10.66 | $159,900 | 158,618 | D |
| 2021-05-06 | Sale : show line 2 in the form | −11,898 | $23.32 | $277,438 | 146,720 | D |
| 2021-05-06 | Sale : show line 3 in the form | −3,102 | $23.86 | $74,016 | 143,618 | D |
| 2021-05-07 | Exercise or conversion : show line 4 in the form | +5,416 | $10.66 | $57,735 | 149,034 | D |
| 2021-05-07 | Sale : show line 5 in the form | −3,316 | $23.23 | $77,016 | 145,718 | D |
| 2021-05-07 | Sale : show line 6 in the form | −2,100 | $23.99 | $50,376 | 143,618 | D |
| Open-market sales · 20,416 sh · avg $23.45 · $478,845 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-06 | Exercise or conversion : show line 7 in the form Employee Stock Option (Right to Buy) | −15,000 | 5,416 | D |
| 2021-05-07 | Exercise or conversion : show line 8 in the form Employee Stock Option (Right to Buy) | −5,416 | 0 | D |
Loading xslF345X03/doc4.xml…